Qube Research & Technologies LTD Sage Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 165,190 shares of SAGE stock, worth $898,633. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165,190
Previous 234,021
29.41%
Holding current value
$898,633
Previous $2.54 Million
53.13%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SAGE
# of Institutions
198Shares Held
46.5MCall Options Held
402KPut Options Held
209K-
Vanguard Group Inc Valley Forge, PA5.76MShares$31.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.59MShares$30.4 Million0.64% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$28.4 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$24.3 Million0.54% of portfolio
-
State Street Corp Boston, MA2.93MShares$15.9 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $323M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...